Reassuring RNS18 Mar 2021 07:24
Leeds, 18 March 2021 - Tissue Regenix (AIM: TRX), the regenerative medical devices company, announces the completion of the initial phase of its expansion plan at the Company's San Antonio Texas facility. As previously disclosed, the Company had secured a ten-year lease on a 21,000 sq. ft facility adjacent to its existing facility to address manufacturing capacity constraints.